ORIGIN Trial (Background, Results)
ORIGIN — the longest and most extensive study on Lantus® use in patients with cardiovascular risk with diabetes mellitus (DM) type 2 in the early stages, as well as prediabetes, in which insulin therapy is not indicated now. ORIGIN trial was initiated to investigate the efficacy of therapy with insu...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Publishing House Zaslavsky
2013-02-01
|
Series: | Mìžnarodnij Endokrinologìčnij Žurnal |
Online Access: | http://iej.zaslavsky.com.ua/article/view/84046 |